Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Simone Augustinus
Regional variation for tumour-directed treatment and survival in patients with pancreatic adenocarcinoma: a nationwide population-based analysis.
Keywords regional variation pancreatic cancer resection chemotherapy survival Get full text access Log in, subscribe or purchase for full access. References 1. Latenstein, AEJ ∙ van der Geest, LGM ∙ Bonsing, B.A. ... Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma European journal of cancer. 2020; 125:83-93 2. Niksic, M. ∙ Matz, M. ∙ Valkov, M. ...
Routine Imaging or Symptomatic Follow-Up After Resection of Pancreatic Adenocarcinoma
Routine Imaging or Symptomatic Follow-Up After Resection of Pancreatic Adenocarcinoma Key Points Question Are there differences in receiving recurrence-focused treatment and overall survival in patients with pancreatic ductal adenocarcinoma (PDAC) recurrence who received symptomatic follow-up vs routine imaging after pancreatic resection? Findings In this international cross-sectional study including 333 patients from 33 centers, most patients received routine imaging after pancreatic resection.
Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands
Key Points Question Can enhanced nationwide implementation of guideline-based best practices in the Netherlands in pancreatic cancer care improve 1-year survival? Findings In this Dutch multicenter, stepped-wedge randomized clinical trial including 5887 patients, 1-year survival was 24% after implementation of 5 best practices compared with 23% before, and did not significantly differ.
Cancers | Free Full-Text | Timing of Initiation of Palliative Chemotherapy in Asymptomatic Patients with Metastatic Pancreatic Cancer: An International Expert Survey and Case-Vignette Study
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Ontwikkelingen in de zorg voor patiënten met pancreascarcinoom
Patiënten die de diagnose ‘pancreascarcinoom’ krijgen, zijn in te delen in drie groepen.1 De eerste groep bestaat uit de circa 20% patiënten met een resectabel of ‘borderline’ resectabel pancreascarcinoom, bij wie de tumor beperkt is tot het pancreas, met geen tot minimale ingroei in het omliggende weefsel. Deze patiënten komen in aanmerking voor een in opzet curatieve resectie, in combinatie met chemotherapie en soms ook radiotherapie.
Radical resection rates of pancreatic cancer in the era of centralization, neoadjuvant therapy, and standardized pathology reporting: a nationwide analysis
Background: Pancreatic cancer care continues to evolve due to centralization of care, (neo)adjuvant chemo(radio)therapy, minimally invasive surgery, and standardized pathology reporting. These changes may influence the rate of radical resection (R0). This study aims to give an overview of the effects of these changes on R0 rates for pancreatic cancer.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Simone
Contact Simone, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack